Perth, Western Australia-based licensed producer Little Green Pharma and national private health insurer Health Insurance Fund of Australia have inked a strategic partnership that will expand access to medical cannabis.
The partnership also encompasses research into medical cannabis, the companies announced this week.
Expanded insurance coverage is seen as key to improving affordability and growing the number of accessible patients for businesses in the regulated market.
Australia added 5,972 medical cannabis approvals in October, bringing the total number of approvals this year to over 45,000.
“This is certainly a watershed moment,” industry consultant Rhys Cohen told Marijuana Business Daily.
“An insurance company has finally figured out they can attract more customers by advertising their cannabis coverage.”
HIF will offer rebates for Little Green Pharma’s medical cannabis products up to 105 Australian dollars ($76) per prescription.
The deal “represents the first time a major Australian health fund has publicly declared its support for access to medicinal cannabis treatments …” the insurance company said in a news release.
The CEO of Health Insurance Fund of Australia said the company is the first Australian health fund to publicly declare its support for medical cannabis treatments and provide members with rebates.
Shares of Little Green Pharma are traded on the Australian Securities Exchange as LGP.
Source link
English
Arabic
Chinese (Simplified)
Dutch
French
German
Italian
Portuguese
Russian
Spanish